
Open-Angle Glaucoma (OAG) Market Trend Analysis Research by Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type), By Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Global Forecast to 2034.
Feb-2025 Formats | PDF | Category: Pharma and Healthcare | Delivery: 24 to 72 Hours

“The Open-Angle Glaucoma (OAG) industry is expected to expand from $6.34 Billion in 2025 to $ 11.46 Billion in 2034, with a compound annual growth rate of 6.9%. “
Open-Angle Glaucoma (OAG) Market: Overview and Growth in the Upcoming Year
Open-Angle Glaucoma (OAG) is a common eye condition affecting millions worldwide, causing optic nerve injury due to elevated intraocular pressure. The market for OAG treatment is expanding due to advancements in technology and drugs. OAG causes the eye’s drainage angle to remain open, partially blocking the trabecular meshwork, leading to increased intraocular pressure and potential optic nerve injury. Early detection and treatment are crucial, with annual eye exams being essential for early detection.
The global Open-Angle Glaucoma market is expected to grow significantly in the coming year due to factors like an aging population, higher diabetes prevalence, and advancements in diagnostic tools and treatment choices. The market is predicted to reach several billion dollars by the end of the year. New treatment options, including less invasive operations and novel drugs, are expected to boost market growth and improve patient outcomes.
The Open-Angle Glaucoma industry, despite its potential for growth, faces challenges like regulatory barriers, reimbursement issues, and patient awareness. Addressing these requires collaboration across the healthcare system to ensure prompt and appropriate care for patients.
For Insights Consultancy’s latest market intelligence study, “Global Open-Angle Glaucoma (OAG) Market 2025, Growth Opportunities, and Forecast,” provides a comprehensive analysis of the Pharma and healthcare industry. The report includes demand analysis, industry insights, competition intelligence, and a customer database. It also offers strategic insights into future trends, growth determinants, supplier landscape, demand landscape, CAGR, and pricing analysis. The study also includes Porter’s Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps’ Analysis, Market Attractiveness Analysis, BPS Analysis, and Ecosystem Analysis.
Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: https://www.forinsightsconsultancy.com/reports/request-sample-open-angle-glaucoma-oag-market
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 110+ is available for purchase to all the interested stakeholders.
Top Companies Covered In This Report:
- Pfizer Inc.
- Merck & Co. Inc.
- AbbVie Inc
- Novartis AG
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Boston Scientific
- Alcon Inc.
- Bausch Health Companies Inc.
- Hoya Corporation
- Sun Pharmaceutical Industries Ltd.
- Santen Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Théa Pharma
- Glaukos Corporation
- Quantel Medical
- EyePoint Pharmaceuticals Inc.
- iSTAR Medical
- Nicox Ophthalmics
- Visus Therapeutics
- Peregrine Eye Laser and Institute
- Inotek Pharmaceuticals
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2034, Y-o-Y growth rate, and CAGR):
Segment by Disease Type
- Open Angle Glaucoma
- Angle Closure Glaucoma
- Other Disease Type
Segment byDrug Class
- Prostaglandin Analog
- Beta Blockers
- Adrenergic Agonist
- Carbonic Anhydrase Inhibitors
- Others Drug Class
Segment byDistribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Segment by End-User
- Hospitals
- Homecare
- Specialty Clinics
- Other End Users
Subsegments
By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Regional Deep-dive Analysis:
The report provides in-depth qualitative and quantitative data on the Open-Angle Glaucoma (OAG) Market for all of the regions and countries listed below:
- North America includes the United States, Canada, and Mexico.
- Europe includes Germany, France, Italy, the United Kingdom, Scandinavia, Benelux, Russia, and the rest of Europe.
- Asia-Pacific includes Japan, South Korea, India, China, Southeast Asia, and Australia.
- South America (including Brazil, Argentina, and the rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa)
Each country is studied in detail, and the study includes qualitative and quantitative analysis of the Open-Angle Glaucoma (OAG) Market in that country.
North America
North America is a significant market for OAG treatment, having a well-established healthcare infrastructure and a high degree of awareness of the ailment. The United States dominates the market, owing to a huge patient population and a strong emphasis on research and development. Canada also plays an important role in the region, with a growing older population driving demand for OAG therapies.
Europe
Germany, France, and the UK are leading in OAG management due to advanced medical technology and a comprehensive healthcare system, ensuring extensive access to therapies and early diagnosis and screening programs for optimal disease management.
Asia Pacific
The Asia Pacific region is experiencing significant growth in the OAG market due to an aging population and improved healthcare infrastructure. Countries like China, Japan, and India are investing in R&D and partnering with major pharmaceutical corporations to introduce novel therapies.
Middle East
Middle Eastern countries like Saudi Arabia, UAE, and Qatar are enhancing OAG detection and management, despite challenges like limited knowledge and access to specialized care. Government initiatives and partnerships with foreign healthcare providers are expected to drive market growth in the coming years.
Recent News:
- In 2020, the two glaucoma treatments launched by Micro Labs USA were dorzolamide 2% and dorzolamide-timolol. Micro Labs USA plans to issue new ophthalmic products in stages of FDA evaluation and development to meet the increasing demand.
- In 2019, Allergan Plc stated that the New Drug Application (NDA) for Bimatoprost Sustained-Release had been approved by the U.S. FDA. Bimatoprost SR would be the first-ever prolonged, reversible implant for the treatment of individuals with primary open-angle glaucoma or ophthalmic hypertension.
The research provides answers to the following key questions:
- What is the expected growth rate of the Open-Angle Glaucoma (OAG) market from 2025-2034?
- What are the key driving forces shaping the market during the forecast period?
- Who are the major market vendors and what winning strategies have helped them occupy a strong foothold in the Open-Angle Glaucoma (OAG) market?
- What are the prominent market trends influencing the market’s development?
Buy the Complete Report with an Impressive Discount (Up to 30% Off) @: https://www.forinsightsconsultancy.com/buy-now-open-angle-glaucoma-oag-market
Key insights provided by the report that could help you take critical strategic decisions?
- Regional reports analyse product/service consumption and market factors in each region.
- Reports highlight possibilities and dangers for suppliers in the Open-Angle Glaucoma (OAG) business globally.
- The report identifies regions and sectors with the highest growth potential.
- It provides a competitive market ranking of major companies, as well as information on new product launches, partnerships, business expansions, and acquisitions.
- The report includes a comprehensive corporate profile with company overviews, insights, product benchmarks, and SWOT analysis for key market participants.
Customization: We can provide following things 1) On request more company profiles (competitors) 2) Data about particular country or region 3) We will incorporate the same with no additional cost (Post conducting feasibility).
Any Requirement Contact us: https://www.forinsightsconsultancy.com/contact-us/
Table of Contents
- Executive Summary
- Open-Angle Glaucoma (OAG) Market Characteristics
- Open-Angle Glaucoma (OAG) Market Trends And Strategies
- Open-Angle Glaucoma (OAG) Market – Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- Global Open-Angle Glaucoma (OAG) Growth Analysis And Strategic Analysis Framework
5.1. Global Open-Angle Glaucoma (OAG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Open-Angle Glaucoma (OAG) Market Growth Rate Analysis
5.4. Global Open-Angle Glaucoma (OAG) Historic Market Size and Growth, 2019 – 2024, Value ($ Billion)
5.5. Global Open-Angle Glaucoma (OAG) Forecast Market Size and Growth, 2025- 2034, 2034F, Value ($ Billion)
5.6. Global Open-Angle Glaucoma (OAG) Total Addressable Market (TAM)
- Open-Angle Glaucoma (OAG) Market Segmentation
6.1. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Open Angle Glaucoma
Angle Closure Glaucoma
Other Disease Type
6.2. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Prostaglandin Analog
Beta Blockers
Adrenergic Agonist
Carbonic Anhydrase Inhibitors
Others Drug Class
6.3. Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.4. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Primary Open-Angle Glaucoma (POAG)
Secondary Open-Angle Glaucoma
6.6. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Acute Angle-Closure Glaucoma
Chronic Angle-Closure Glaucoma
6.7. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Normal-Tension Glaucoma
Congenital Glaucoma
Secondary Glaucoma
- Open-Angle Glaucoma (OAG) Market Regional And Country Analysis
7.1. Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
7.2. Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Asia-Pacific Open-Angle Glaucoma (OAG) Market
8.1. Asia-Pacific Open-Angle Glaucoma (OAG) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
8.3. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
8.4. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- China Open-Angle Glaucoma (OAG) Market
9.1. China Open-Angle Glaucoma (OAG) Market Overview
9.2. China Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
9.3. China Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
9.4. China Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
- India Open-Angle Glaucoma (OAG) Market
10.1. India Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
10.2. India Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
10.3. India Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Japan Open-Angle Glaucoma (OAG) Market
11.1. Japan Open-Angle Glaucoma (OAG) Market Overview
11.2. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.3. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.4. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Australia Open-Angle Glaucoma (OAG) Market
12.1. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
12.2. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
12.3. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Indonesia Open-Angle Glaucoma (OAG) Market
13.1. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.2. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.3. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South Korea Open-Angle Glaucoma (OAG) Market
14.1. South Korea Open-Angle Glaucoma (OAG) Market Overview
14.2. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.3. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.4. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Western Europe Open-Angle Glaucoma (OAG) Market
15.1. Western Europe Open-Angle Glaucoma (OAG) Market Overview
15.2. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.3. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.4. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- UK Open-Angle Glaucoma (OAG) Market
16.1. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.2. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.3. UK Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Germany Open-Angle Glaucoma (OAG) Market
17.1. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.2. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.3. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- France Open-Angle Glaucoma (OAG) Market
18.1. France Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.2. France Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.3. France Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Italy Open-Angle Glaucoma (OAG) Market
19.1. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.2. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.3. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Spain Open-Angle Glaucoma (OAG) Market
20.1. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.2. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.3. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Eastern Europe Open-Angle Glaucoma (OAG) Market
21.1. Eastern Europe Open-Angle Glaucoma (OAG) Market Overview
21.2. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.3. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.4. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Russia Open-Angle Glaucoma (OAG) Market
22.1. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.2. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.3. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- North America Open-Angle Glaucoma (OAG) Market
23.1. North America Open-Angle Glaucoma (OAG) Market Overview
23.2. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.3. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.4. North America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- USA Open-Angle Glaucoma (OAG) Market
24.1. USA Open-Angle Glaucoma (OAG) Market Overview
24.2. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.3. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.4. USA Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Canada Open-Angle Glaucoma (OAG) Market
25.1. Canada Open-Angle Glaucoma (OAG) Market Overview
25.2. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.3. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.4. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South America Open-Angle Glaucoma (OAG) Market
26.1. South America Open-Angle Glaucoma (OAG) Market Overview
26.2. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.3. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.4. South America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Brazil Open-Angle Glaucoma (OAG) Market
27.1. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.2. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.3. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Middle East Open-Angle Glaucoma (OAG) Market
28.1. Middle East Open-Angle Glaucoma (OAG) Market Overview
28.2. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
28.3. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
28.4. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Africa Open-Angle Glaucoma (OAG) Market
29.1. Africa Open-Angle Glaucoma (OAG) Market Overview
29.2. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
29.3. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
29.4. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Open-Angle Glaucoma (OAG) Market Competitive Landscape And Company Profiles
30.1. Open-Angle Glaucoma (OAG) Market Competitive Landscape
30.2. Open-Angle Glaucoma (OAG) Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- Open-Angle Glaucoma (OAG) Market Other Major And Innovative Companies
31.1. Teva Pharmaceutical Industries Ltd.
31.2. Boston Scientific
31.3. Alcon Inc.
31.4. Bausch Health Companies Inc.
31.5. Hoya Corporation
31.6. Sun Pharmaceutical Industries Ltd.
31.7. Santen Pharmaceuticals
31.8. Mallinckrodt Pharmaceuticals
31.9. Théa Pharma
31.10. Glaukos Corporation
31.11. Quantel Medical
31.12. EyePoint Pharmaceuticals Inc.
31.13. iSTAR Medical
31.14. Nicox Ophthalmics
31.15. Visus Therapeutics
- Global Open-Angle Glaucoma (OAG) Market Competitive Benchmarking And Dashboard
- Key Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market
- Recent Developments In The Open-Angle Glaucoma (OAG) Market
- Open-Angle Glaucoma (OAG) Market High Potential Countries, Segments and Strategies
35.1 Open-Angle Glaucoma (OAG) Market In 2034 – Countries Offering Most New Opportunities
35.2 Open-Angle Glaucoma (OAG) Market In 2034 – Segments Offering Most New Opportunities
35.3 Open-Angle Glaucoma (OAG) Market In 2034 – Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
- Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. For Insights Consultancy
36.6. Copyright And Disclaimer
Select PDF License
Single User: $3499
Multiple Users: $4499
Corporate Users: $5499